The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians on the circulation of a fake meningitis vaccines including MencevaxTM ACWY and MencevaxTM ACW circulating in Niger Republic.
A press statement signed by Prof. Moji Adeyeye, NAFDAC’s Director General reveals that the health authorities in Niger Republic has issued alert on the fake vaccines after it was discovered during routine inspection of pharmacies in Niamey in March 14th 2019.
The Lot number of the fake MencevaxTM ACW vaccine is AMEN A020 AA, while the Lot number of the fake MencevaxTM ACWY is AMEH A020 AA.
Adeyeye said that the fake vaccine had a manufacturing date of December 2016, and an expiring date of November 2021.
Adeyeye said that the genuine vaccines used to control outbreak of meningococcal infection were registered by NAFDAC in favour of Glaxo SmithKline Beecham (GSK), adding that Pfizer acquired the vaccines from GSK in 2015.
Adeyeye warned importers and retailers of pharmaceutical products not to import or sell the fake vaccine.
The NAFDAC boss said that Pfizer discontinued the sale of such vaccine in Nigeria in 2018, adding that NAFDAC had increased surveillance in all ports of entry to prevent the fake vaccine from entry into Nigeria.
“Surveillance has been strengthened by NAFDAC at all ports of entry to prevent importation of the fake vaccines from Niger Republic, and to prevent the distribution and sale of the fake vaccine,” she said.
Adeyeye therefore advised healthcare providers and other members of the public to be vigilant and contact the nearest NAFDAC office with any information on the fake vaccines.
She urged anybody in possession of the fake vaccines to submit such to the nearest NAFDAC office.
She also asked consumers to report adverse events related to the use of vaccines to the nearest NAFDAC office; via NAFDAC PRASCOR (20543 TOLL FREE for all Network ) or via firstname.lastname@example.org.